4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
European Gram Negative Antibacterial Engine (ENABLE)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2020,
The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future medical advances are negated. Resistant bacteria dramatically reduce the possibilities of treating infections effectively, a ...
Voir le projet
42
Participants partenaires
TERMINÉ
Exploiting plants for the production of future generation recombinant pharmaceuticals (FUTURE-PHARMA)
Date du début: 1 août 2011, Date de fin: 31 janv. 2018,
Biopharmaceutical proteins are typically produced in cultivated mammalian cells, a costly process with limited scalability. Thus products such as monoclonal antibodies are very expensive and often beyond the reach of the world’s poor. The problem is compounded by the fact that important strategies for preventing diseases such as HIV and rabies typically involve large doses of multiple antibodies a ...
Voir le projet
2
Participants partenaires
TERMINÉ
Biomarkers For Enhanced Vaccine Safety (BIOVACSAFE)
Date du début: 1 mars 2012, Date de fin: 31 déc. 2016,
BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and generalizable guidelines and techniques to enhance immunosafety of novel vaccines from pre-development to post-marketing surveil ...
Voir le projet
24
Participants partenaires
TERMINÉ
Development of a handheld antimalarial drug resistance diagnostic device using nanowire technology (NANOMAL)
Date du début: 1 juil. 2012, Date de fin: 30 juin 2015,
"Malaria is a global health priority that has been targeted for elimination in recent years. Attaining the goals that define elimination of malaria in different countries depends critically on provision of effective antimalarials and further that these antimalarials are used appropriately in individual patients. Drug resistance is a major threat to malaria control and has important global public h ...
Voir le projet